NCT02912494View on ClinicalTrials.gov

A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Anemia
Interventions
DRUG

JR-131

DRUG

Darbepoetin alfa

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
collaborator

JCR Pharmaceuticals Co., Ltd.

INDUSTRY

lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT02912494 - A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) | Biotech Hunter | Biotech Hunter